JP2014501758A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014501758A5 JP2014501758A5 JP2013546071A JP2013546071A JP2014501758A5 JP 2014501758 A5 JP2014501758 A5 JP 2014501758A5 JP 2013546071 A JP2013546071 A JP 2013546071A JP 2013546071 A JP2013546071 A JP 2013546071A JP 2014501758 A5 JP2014501758 A5 JP 2014501758A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- ligand
- domain
- domains
- asparagine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010025221 plasma protein Z Proteins 0.000 claims 15
- 235000018102 proteins Nutrition 0.000 claims 14
- 108090000623 proteins and genes Proteins 0.000 claims 14
- 102000004169 proteins and genes Human genes 0.000 claims 14
- 239000003446 ligand Substances 0.000 claims 13
- 238000000034 method Methods 0.000 claims 8
- 108060003951 Immunoglobulin Proteins 0.000 claims 6
- 235000001014 amino acid Nutrition 0.000 claims 6
- 229940024606 amino acid Drugs 0.000 claims 6
- 150000001413 amino acids Chemical class 0.000 claims 6
- 102000018358 immunoglobulin Human genes 0.000 claims 6
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 5
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 5
- 229960001230 asparagine Drugs 0.000 claims 5
- 235000009582 asparagine Nutrition 0.000 claims 5
- 239000011159 matrix material Substances 0.000 claims 5
- 239000000178 monomer Substances 0.000 claims 5
- 108010088160 Staphylococcal Protein A Proteins 0.000 claims 4
- 238000010828 elution Methods 0.000 claims 4
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 claims 3
- 235000004279 alanine Nutrition 0.000 claims 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 238000000926 separation method Methods 0.000 claims 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- 102100035971 Molybdopterin molybdenumtransferase Human genes 0.000 claims 1
- 101710119577 Molybdopterin molybdenumtransferase Proteins 0.000 claims 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims 1
- 239000003513 alkali Substances 0.000 claims 1
- 239000003480 eluent Substances 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061424725P | 2010-12-20 | 2010-12-20 | |
| US61/424,725 | 2010-12-20 | ||
| PCT/SE2011/051536 WO2012087230A1 (en) | 2010-12-20 | 2011-12-19 | Affinity chromatography matrix |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014501758A JP2014501758A (ja) | 2014-01-23 |
| JP2014501758A5 true JP2014501758A5 (enExample) | 2015-02-05 |
| JP5974342B2 JP5974342B2 (ja) | 2016-08-23 |
Family
ID=46314245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013546071A Active JP5974342B2 (ja) | 2010-12-20 | 2011-12-19 | アフィニティークロマトグラフィーマトリックス |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9683013B2 (enExample) |
| EP (1) | EP2654915B1 (enExample) |
| JP (1) | JP5974342B2 (enExample) |
| CN (1) | CN103269761B (enExample) |
| WO (1) | WO2012087230A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG195555A1 (en) | 2008-12-24 | 2013-12-30 | Emd Millipore Corp | Caustic stable chromatography ligands |
| SG186552A1 (en) | 2011-06-08 | 2013-01-30 | Emd Millipore Corp | Chromatography matrices including novel staphylococcus aureus protein a based ligands |
| WO2013018880A1 (ja) * | 2011-08-04 | 2013-02-07 | 独立行政法人産業技術総合研究所 | プロテインgの細胞膜外ドメイン変異体のタンデム型多量体から成る新規な改変型タンパク質 |
| US9657055B2 (en) * | 2011-11-30 | 2017-05-23 | Ge Healthcare Bioprocess R&D Ab | Affinity chromatography matrix |
| US10189891B2 (en) * | 2012-03-28 | 2019-01-29 | Ge Healthcare Bioprocess R&D Ab | Affinity chromatography matrix |
| MY178616A (en) | 2012-09-17 | 2020-10-19 | Grace W R & Co | Chromatography media and devices |
| SG11201605712SA (en) | 2014-01-16 | 2016-08-30 | Grace W R & Co | Affinity chromatography media and chromatography devices |
| CN104945488B (zh) * | 2014-03-27 | 2020-02-18 | 迈格生物医药（上海）有限公司 | 一种具有免疫球蛋白结合能力的多肽 |
| CN107847907A (zh) | 2014-05-02 | 2018-03-27 | 格雷斯公司 | 官能化载体材料以及制备和使用官能化载体材料的方法 |
| US11566082B2 (en) | 2014-11-17 | 2023-01-31 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
| EP3233891B1 (en) * | 2014-12-17 | 2024-03-13 | Cytiva BioProcess R&D AB | Modified kappa light chain-binding polypeptides |
| BR112017026193B1 (pt) | 2015-06-05 | 2021-09-14 | W.R. Grace & Co-Conn | Adsorventes, método de produção dos adsorventes e uso dos adsorventes |
| GB201515339D0 (en) * | 2015-08-28 | 2015-10-14 | Ge Healthcare Bio Sciences Ab | A seperation matrix and a method of seperating antibodies |
| JP7031934B2 (ja) | 2016-05-11 | 2022-03-08 | サイティバ・バイオプロセス・アールアンドディ・アクチボラグ | 分離マトリックス |
| CN109071613A (zh) | 2016-05-11 | 2018-12-21 | 通用电气医疗集团生物工艺研发股份公司 | 分离基质 |
| US11708390B2 (en) | 2016-05-11 | 2023-07-25 | Cytiva Bioprocess R&D Ab | Method of storing a separation matrix |
| US11753438B2 (en) | 2016-05-11 | 2023-09-12 | Cytiva Bioprocess R&D Ab | Method of cleaning and/or sanitizing a separation matrix |
| US10703774B2 (en) | 2016-09-30 | 2020-07-07 | Ge Healthcare Bioprocess R&D Ab | Separation method |
| US10654887B2 (en) | 2016-05-11 | 2020-05-19 | Ge Healthcare Bio-Process R&D Ab | Separation matrix |
| US10730908B2 (en) | 2016-05-11 | 2020-08-04 | Ge Healthcare Bioprocess R&D Ab | Separation method |
| US10889615B2 (en) | 2016-05-11 | 2021-01-12 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
| KR101857953B1 (ko) | 2016-07-06 | 2018-05-16 | 아미코젠주식회사 | 알칼리 내성이 증가된 변이 면역글로불린 결합 단백질 |
| GB201615254D0 (en) * | 2016-09-08 | 2016-11-23 | Ge Healthcare Bio Sciences Ab | Novel Ligand and use thereof |
| US12448411B2 (en) | 2016-09-30 | 2025-10-21 | Cytiva Bioprocess R&D Ab | Separation method |
| WO2018151743A1 (en) | 2017-02-15 | 2018-08-23 | Bioprocessia Technologies Llc | Affinity chromatography ligands with mild elution ph |
| GB201708277D0 (en) | 2017-05-24 | 2017-07-05 | Ge Healthcare | A Recombinant protein |
| EP3875472A1 (en) * | 2020-03-06 | 2021-09-08 | Navigo Proteins Gmbh | Novel immunoglobulin binding polypeptides |
| WO2022081779A1 (en) | 2020-10-13 | 2022-04-21 | Avitide LLC | Affinity ligand libraries of three-helix bundle proteins and uses thereof |
| GB202018588D0 (en) | 2020-11-26 | 2021-01-13 | Cytiva Bioprocess R & D Ab | Separation matrix |
| EP4294542A1 (en) | 2021-02-19 | 2023-12-27 | Avitide LLC | Aav2 affinity agents |
| GB202113626D0 (en) | 2021-09-24 | 2021-11-10 | Cytiva Bioprocess R & D Ab | FC binding polypeptides |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8505922D0 (sv) | 1985-12-13 | 1985-12-13 | Kabigen Ab | Construction of an igg binding protein to facilitate downstream processing using protein engineering |
| US6602977B1 (en) * | 1999-04-19 | 2003-08-05 | Biovitrum Ab | Receptor structures |
| US7709209B2 (en) | 2002-03-25 | 2010-05-04 | Ge Healthcare Bio-Sciences Ab | Protein ligands |
| SE0200943D0 (sv) * | 2002-03-25 | 2002-03-25 | Amersham Biosciences Ab | Mutant protein |
| DK1641818T3 (da) | 2003-07-04 | 2009-03-16 | Affibody Ab | Polypeptider der har bindingsaffinitet for HER2 |
| SE0400274D0 (sv) * | 2004-02-09 | 2004-02-09 | Affibody Ab | New polypeptide |
| ATE490268T1 (de) | 2005-03-01 | 2010-12-15 | Affibody Ab | Tnf-alhpa-bindendes polypeptid, anwendungen davon und verfahren, bei denen dieses verwendet wird |
| WO2007019376A2 (en) * | 2005-08-03 | 2007-02-15 | Rq Bioscience, Inc. | Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases |
| JP5229888B2 (ja) * | 2008-09-30 | 2013-07-03 | 独立行政法人産業技術総合研究所 | 弱酸性域での易解離性を向上したプロテインａ変異型タンパク質及び抗体捕捉剤 |
| JP2012515160A (ja) | 2009-01-12 | 2012-07-05 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | アフィニティークロマトグラフィーマトリックス |
-
2011
- 2011-12-19 CN CN201180061114.1A patent/CN103269761B/zh active Active
- 2011-12-19 US US13/996,023 patent/US9683013B2/en active Active
- 2011-12-19 EP EP11850413.3A patent/EP2654915B1/en active Active
- 2011-12-19 WO PCT/SE2011/051536 patent/WO2012087230A1/en not_active Ceased
- 2011-12-19 JP JP2013546071A patent/JP5974342B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014501758A5 (enExample) | ||
| JP2014500311A5 (enExample) | ||
| JP2012515160A5 (enExample) | ||
| JP2014502272A5 (enExample) | ||
| Gutierrez et al. | Immobilized metal‐ion affinity chromatography: status and trends | |
| Gaberc‐Porekar et al. | Potential for using histidine tags in purification of proteins at large scale | |
| Zhao et al. | Biomimetic design of affinity peptide ligands for human IgG based on protein A-IgG complex | |
| Zachariou et al. | Application of immobilized metal ion chelate complexes as pseudocation exchange adsorbents for protein separation | |
| JP2019531055A5 (enExample) | ||
| US20100069617A1 (en) | Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions | |
| CN107001432A (zh) | 突变的免疫球蛋白结合多肽 | |
| JP2019034963A (ja) | 陽イオン交換基を用いた新規抗体精製法（Ｎｏｖｅｌ Ａｎｔｉｂｏｄｙ Ｐｕｒｉｆｉｃａｔｉｏｎ ｍｅｔｈｏｄ ｕｓｉｎｇ Ｃａｔｉｏｎ Ｅｘｃｈａｎｇｅｒ） | |
| CN103270044A (zh) | 亲和色谱用载体和分离免疫球蛋白的方法 | |
| JP2016525100A5 (enExample) | ||
| JP2007532477A5 (enExample) | ||
| EP4371996A3 (en) | Methods for purifying antibodies | |
| Nian et al. | Void exclusion of antibodies by grafted-ligand porous particle anion exchangers | |
| RU2014118552A (ru) | Способ выделения фукозилированных антител | |
| CN104603153B (zh) | 用于抗体纯化的载体、其制备方法及其应用 | |
| Kish et al. | Peptide-based affinity adsorbents with high binding capacity for the purification of monoclonal antibodies | |
| Scheffel et al. | Optimization of a calcium-dependent Protein A-derived domain for mild antibody purification | |
| JP2015518489A5 (enExample) | ||
| Roy et al. | Current trends in affinity-based separations of proteins/enzymes | |
| Opitz et al. | Purification of cell culture-derived influenza virus A/Puerto Rico/8/34 by membrane-based immobilized metal affinity chromatography | |
| JP2011001336A (ja) | 新規なプロテインａ固定化担体の製造方法 |